Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial
Autor: | Jeff K. Vallance, Brigid M. Lynch, Dori E. Rosenberg, Terry Boyle, Marina M. Reeves, Nga H. Nguyen, Melissa M. Moore, Dallas R. English, Michael Wheeler, Christine M. Friedenreich |
---|---|
Přispěvatelé: | Lynch, Brigid M, Nguyen, Nga H, Reeves, Marina M, Moore, Melissa M, Rosenberg, Dori E, Wheeler, Michael J, Boyle, Terry, Vallance, Jeff K, Friedenreich, Christine M, English, Dallas R |
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
Health coaching breast cancer survivors Population Motivational interviewing physical activity Breast Neoplasms Context (language use) Health Promotion Motivational Interviewing law.invention Wearable Electronic Devices 03 medical and health sciences wearable technology 0302 clinical medicine Quality of life (healthcare) Physical medicine and rehabilitation Breast cancer Cancer Survivors Randomized controlled trial law sedentary behaviour Health care Humans Medicine Pharmacology (medical) 030212 general & internal medicine education Exercise Aged Neoplasm Staging education.field_of_study business.industry Australia General Medicine Middle Aged medicine.disease Telephone Postmenopause Research Design 030220 oncology & carcinogenesis Quality of Life Physical therapy activity trackers Sedentary Behavior business |
Zdroj: | Contemporary Clinical Trials. 64:112-117 |
ISSN: | 1551-7144 |
Popis: | Background: Physical activity is positively associated with survival and quality of life among breast cancer survivors. Despite these benefits, the majority of breast cancer survivors are insufficiently active. The potential health benefits of reducing sedentary behaviour (sitting time) in this population have not been extensively investigated. The ACTIVATE Trial will evaluate the efficacy of an intervention that combines wearable technology (the Garmin Vivofit2®) with traditional behavioural change approaches to increase physical activity and reduce sedentary behaviour performed by breast cancer survivors. Methods/design: This randomised controlled trial includes inactive, postmenopausal women diagnosed with stage I-III breast cancer who have completed their primary treatment. Participants are randomly assigned to the primary intervention group (Garmin Vivofit2®; behavioural feedback and goal setting session; and, five telephone-delivered health coaching sessions) or to the wait-list control group. The primary intervention is delivered over a 12-week period. The second 12-week period comprises a maintenance phase for the primary intervention group, and an abridged intervention (Garmin Vivofit2® only) for the wait-list control group. Moderate- to vigorous-intensity physical activity (MVPA) and sedentary behaviour are assessed by accelerometry at baseline (T1), end of intervention (T2), and end of maintenance phase (T3). Discussion: The ACTIVATE Trial is one of the first studies to incorporate wearable technology into an intervention for cancer survivors. If the use of wearable technology (in combination with behaviour change strategies, or alone) proves efficacious, it may become an inexpensive and sustainable addition to the health promotion strategies available to health care providers in the cancer survivorship context. Trial registration: ACTRN12616000175471. Refereed/Peer-reviewed |
Databáze: | OpenAIRE |
Externí odkaz: |